The Experts below are selected from a list of 322251 Experts worldwide ranked by ideXlab platform

Luella Klein - One of the best experts on this subject based on the ideXlab platform.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American Journal of Obstetrics and Gynecology, 1991
    Co-Authors: Michael K. Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    Abstract To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of “crack” cocaine use emerged as a significant risk factor for infection (p \lt 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American journal of obstetrics and gynecology, 1991
    Co-Authors: M K Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of "crack" cocaine use emerged as a significant risk factor for infection (p less than 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

Michael K. Lindsay - One of the best experts on this subject based on the ideXlab platform.

  • A protocol for routine voluntary antepartum Human Immunodeficiency Virus antibody screening
    American Journal of Obstetrics and Gynecology, 1993
    Co-Authors: Michael K. Lindsay
    Abstract:

    Human Immunodeficiency Virus infection among both women of reproductive age and their infants is rapidly increasing. One strategy to address this increase involves the offering of routine voluntary antepartum Human Immunodeficiency Virus antibody counseling and testing. The rationale for this policy is that all prenatal patients are educated about the major modes of viral transmission and encouraged to practice risk reduction behavior. Human Immunodeficiency Virus-infected women receive comprehensive prenatal care; they are referred for medical follow-up, and their infants are identified and targeted for pediatric infectious disease follow-up. During the past 4 years we have developed a protocol for antepartum Human Immunodeficiency Virus screening in our institution. The protocol includes a self-reported Human Immunodeficiency Virus risk behavior profile, pretest counseling conducted by trained Human Immunodeficiency Virus counselors in small groups, written informed consent for Human Immunodeficiency Virus antibody testing, posttest counseling, and education. By following this protocol we have identified and referred for follow-up > 350 Human Immunodeficiency Virus-infected women.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American Journal of Obstetrics and Gynecology, 1991
    Co-Authors: Michael K. Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    Abstract To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of “crack” cocaine use emerged as a significant risk factor for infection (p \lt 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

Harriet Williams - One of the best experts on this subject based on the ideXlab platform.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American Journal of Obstetrics and Gynecology, 1991
    Co-Authors: Michael K. Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    Abstract To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of “crack” cocaine use emerged as a significant risk factor for infection (p \lt 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American journal of obstetrics and gynecology, 1991
    Co-Authors: M K Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of "crack" cocaine use emerged as a significant risk factor for infection (p less than 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

Joanne Gramling - One of the best experts on this subject based on the ideXlab platform.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American Journal of Obstetrics and Gynecology, 1991
    Co-Authors: Michael K. Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    Abstract To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of “crack” cocaine use emerged as a significant risk factor for infection (p \lt 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American journal of obstetrics and gynecology, 1991
    Co-Authors: M K Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of "crack" cocaine use emerged as a significant risk factor for infection (p less than 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

Barbara A. Slade - One of the best experts on this subject based on the ideXlab platform.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American Journal of Obstetrics and Gynecology, 1991
    Co-Authors: Michael K. Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    Abstract To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of “crack” cocaine use emerged as a significant risk factor for infection (p \lt 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.

  • Incidence and prevalence of Human Immunodeficiency Virus infection in a prenatal population undergoing routine voluntary Human Immunodeficiency Virus screening, July 1987 to June 1990.
    American journal of obstetrics and gynecology, 1991
    Co-Authors: M K Lindsay, Herbert B. Peterson, Susan Willis, Barbara A. Slade, Joanne Gramling, Harriet Williams, Luella Klein
    Abstract:

    To characterize the epidemiologic characteristics of Human Immunodeficiency Virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal Human Immunodeficiency Virus antibody testing and obtained self-reported Human Immunodeficiency Virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to Human Immunodeficiency Virus antibody testing and completed risk behavior profiles. The cumulative incidence of Human Immunodeficiency Virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of "crack" cocaine use emerged as a significant risk factor for infection (p less than 0.01). The majority (70%) of Human Immunodeficiency Virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of Human Immunodeficiency Virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal Human Immunodeficiency Virus screening and risk behavior assessment.